News
Agilent Announces Cash Dividend of 19.4 Cents per Share
Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 19.4 cents per share of common stock will be paid on April 28, 2021, to all shareholders of record as of the close
Der erste Patient schließt in Phase IIb die digitale Einwilligung mit dem Veeva Clinical Network ab
Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Veeva eConsent, eine MyVeeva for Patients-Anwendung, die auf dem Veeva Clinical Network basiert, von seinem ersten Patienten eine elektronische
Survey: Provider Burnout and Disengagement Seen as Most Potentially Disruptive Forces in Healthcare
The most potentially disruptive forces facing hospitals and health systems in the next three years are provider burnout, disengagement, and resulting shortages among healthcare professionals
Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS)
Premier Inc. to Participate in KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on March 23, 2021
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to present at the KeyBanc Capital Markets Virtual Life
EUROIMMUN bringt ultraschnelles automatisiertes Mikroskop und intelligente Software für moderne Befunderhebung am Bildschirm auf den Markt
EUROIMMUN, a PerkinElmer, Inc. company, gab heute die Markteinführung des kompakten Immunfluoreszenz-Mikroskops EUROPattern Microscope Live (EPML) mit EUROLabOffice 4.0 (ELO 4.0), der vierten
Humana Introduces CenterWell as the New Brand for a Range of Its Payer-Agnostic Health Care Services Offerings
Leading health and well-being company Humana Inc. (NYSE: HUM) announced today a new brand – CenterWell – to describe and connect a range of the company’s payer-agnostic health care services
First Patient Completes Digital Consent with Veeva Clinical Network in Phase 2b Study
Veeva Systems (NYSE: VEEV) today announced that Veeva eConsent, a MyVeeva for Patients application built on Veeva Clinical Network, had its first patient complete an electronic consent for an early
First Patient Completes Digital Consent with Veeva Clinical Network in Phase 2b Study
Veeva Systems (NYSE: VEEV) today announced that Veeva eConsent, a MyVeeva for Patients application built on Veeva Clinical Network, had its first patient complete an electronic consent for an early
Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence
Agilent Technologies Inc. (NYSE: A) today introduced the Agilent 8697 Headspace Sampler, the first headspace sampler with integrated gas chromatography communication. It marks the expansion of
Chemed Corporation to Present at the Oppenheimer 31st Annual Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021, at approximately 8:40
Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
Illumina, Inc. (NASDAQ: ILMN), along with researchers at the University of Colorado and Harvard Pilgrim Health Care (HPHC), reported study results evaluating the impact of an innovative
Waters Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector
Waters Corporation (NYSE:WAT) today released the ACQUITY RDa™ Detector featuring SmartMS™, the company’s newest time-of-flight (TOF) mass spectrometer (MS) for small molecule analysis for
Dr. Katharine Knobil Named Agilent’s First Chief Medical Officer
Agilent Technologies Inc. (NYSE: A), today announced that Dr. Katharine (Kate) Knobil is joining Agilent as the company’s chief medical officer (CMO). The chief medical officer at Agilent is a
Simulations Plus to Present at Oppenheimer Healthcare Conference
Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn
PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations
PerkinElmer, Inc. (NYSE:PKI) today announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX®
PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC
PerkinElmer, Inc., (NYSE: PKI) a global leader committed to innovating for a healthier world, today announced that the Company has completed its previously announced acquisition of Oxford Immunotec
Agilent Completes CE-IVD Registration of qRT-PCR In Vitro Diagnostic Kit for SARS-CoV-2 RNA Detection
Agilent Technologies Inc. (NYSE: A) today announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in
Neue Studie zeigt auf, dass mehr Auftragsforschungsinstitute Maßnahmen ergreifen, um dem dringenden Bedarf an schnelleren klinischen Studien gerecht zu werden
Auftragsforschungsinstitute machen bedeutende Fortschritte bei der Modernisierung und Verkürzung klinischer Studien, so die Ergebnisse der aktuellen Veeva Unified Clinical Operations Survey: Annual
Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
Illumina, Inc.’s (NASDAQ: ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously
PerkinElmer Prices Offering of Senior Notes
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550%
New Research Reveals More CROs Taking Action to Meet Urgent Need for Faster Clinical Trials
Contract research organizations (CROs) are making significant advancements to modernize and speed clinical trials, according to the latest Veeva Unified Clinical Operations Survey: Annual CRO
New Research Reveals More CROs Taking Action to Meet Urgent Need for Faster Clinical Trials
Contract research organizations (CROs) are making significant advancements to modernize and speed clinical trials, according to the latest Veeva Unified Clinical Operations Survey: Annual CRO
Agilent Technologies Announces Pricing of $850 Million of Senior Notes
Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $850 million. The